top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
Leqembi Approved for Alzheimer’s Treatment in the UAE | iPharmaCenter
Eisai and Biogen have announced that the United Arab Emirates (UAE) Ministry of Health and Prevention has granted approval for Leqembi...
South Korea | MFDS Drug Approvals | Updates | 2024 | iPharmaCenter
LEQEMBI (Lecanemab) Gains Approval in South Korea for Alzheimer’s Disease Treatment EiSai and Biogen have announced that South Korea's...
South Korea Drug approvals | Updates | MFDS | iPharmaCenter
Eisai submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety (MFDS) to seek approval for...
bottom of page